Spironolactone improves carotid artery fibrosis and distensibility in rat post-ischaemic heart failure

Journal of Molecular and Cellular Cardiology

Volumn 39, Issue 3, 2005, Pages 511-519

  Nehme, Johnny A ^a   Lacolley, Patrick ^b   Labat, Carlos ^b   Challande, Pascal ^c   Robidel, Estelle ^a   Perret, Claudine ^b   Leenhardt, Antoine ^a   Safar, Michel E ^d   Delcayre, Claude ^a   Milliez, Paul ^a  

^a HÔPITAL LARIBOISIÈRE   (France)

^b CENTRE DE RECHERCHE DES CORDELIERS   (France)

^c SORBONNE UNIVERSITÉ   (France)

^d HÔTEL DIEU   (France)

Author keywords

Aldosterone; Angiotensin II; Blood pressure; Carotid fibrosis; Congestive heart failure; Distensibility

Indexed keywords

ALDOSTERONE; ANGIOTENSIN; COLLAGEN; LISINOPRIL; SPIRONOLACTONE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERY COMPLIANCE; ARTICLE; CAROTID ARTERY DISEASE; COLLAGEN SYNTHESIS; COMPARATIVE STUDY; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DOPPLER ECHOCARDIOGRAPHY; DRUG EFFECT; ENZYME INHIBITION; HEART INFARCTION; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE PRESSURE; HEART VENTRICLE WALL; HEART WEIGHT; MORPHOMETRICS; NONHUMAN; PRIORITY JOURNAL; RAT; RAT STRAIN; SHAM FEEDING; STATISTICAL ANALYSIS; VASCULAR FIBROSIS;

ANIMALS; CAROTID ARTERIES; COMPLIANCE; DRUG THERAPY, COMBINATION; ECHOCARDIOGRAPHY; ELASTICITY; FIBROSIS; HEART FAILURE, CONGESTIVE; LISINOPRIL; MALE; MYOCARDIAL ISCHEMIA; RANDOM ALLOCATION; RATS; RATS, WISTAR; SPIRONOLACTONE; TIME FACTORS; VENTRICULAR FUNCTION, LEFT;

RATTUS NORVEGICUS;

EID: 23644435630     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2005.05.015     Document Type: Article

References (57)

1. M.F. O'Rourke Arterial hemodynamics in hypertension Circ. Res. 27 Suppl 2 1970 123
2. G.F. Mitchell, J.L. Izzo Jr., Y. Lacourciere, J.P. Ouellet, J. Neutel, and C. Qian Omapatrilat reduces pulse pressure and proximal aortic stiffness in patients with systolic hypertension: results of the conduit hemodynamics of omapatrilat international research study Circulation 105 25 2002 2955 2961
3. G.F. Mitchell, J.C. Tardif, J.M. Arnold, G. Marchiori, T.X. O'Brien, and M.E. Dunlap Pulsatile hemodynamics in congestive heart failure Hypertension 38 6 2001 1433 1439
4. C. Giannattasio, F. Achilli, M. Failla, A. Capra, A. Vincenzi, and F. Valagussa Radial, carotid and aortic distensibility in congestive heart failure: effects of high-dose angiotensin-converting enzyme inhibitor or low-dose association with angiotensin type 1 receptor blockade J. Am. Coll. Cardiol. 39 8 2002 1275 1282
5. H. Drexler, A.M. Zeiher, H. Wollschlager, T. Meinertz, H. Just, and T. Bonzel Flow-dependent coronary artery dilatation in humans Circulation 80 3 1989 466 474
6. M.A. Gaballa, T.E. Raya, and S. Goldman Large artery remodeling after myocardial infarction Am. J. Physiol. 268 5 Pt 2 1995 H2092 H2103
7. F.R. Stassen, G.E. Fazzi, P.J. Leenders, J.F. Smits, and J.G. De Mey Coronary arterial hyperreactivity and mesenteric arterial hyporeactivity after myocardial infarction in the rat J. Cardiovasc. Pharmacol. 29 6 1997 780 788
8. A.B. Driss, C. Himbert, P. Poitevin, M. Duriez, J.B. Michel, and B.I. Levy Enalapril improves arterial elastic properties in rats with myocardial infarction J. Cardiovasc. Pharmacol. 34 1 1999 102 107
9. B. Pitt, F. Zannad, W.J. Remme, R. Cody, A. Castaigne, and A. Perez The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized aldactone evaluation study investigators N. Engl. J. Med. 341 10 1999 709 717
10. P. Albaladejo, H. Bouaziz, M. Duriez, P. Gohlke, B.I. Levy, and M.E. Safar Angiotensin converting enzyme inhibition prevents the increase in aortic collagen in rats Hypertension 23 1 1994 74 82
11. A. Benetos, P. Lacolley, and M.E. Safar Prevention of aortic fibrosis by spironolactone in spontaneously hypertensive rats Arterioscler. Thromb. Vasc. Biol. 17 6 1997 1152 1156
12. L.M. Pereira, and C.A. Mandarim-de-Lacerda Myocardial changes after spironolactone in spontaneous hypertensive rats. A laser scanning confocal microscopy study J. Cell. Mol. Med. 6 1 2002 49 57
13. J.A. Delyani, E.L. Robinson, and A.E. Rudolph Effect of a selective aldosterone receptor antagonist in myocardial infarction Am. J. Physiol. Heart Circ. Physiol. 281 2 2001 H647 H654
14. L.B. Tan, C. Brilla, and K.T. Weber Prevention of structural changes in the heart in hypertension by angiotensin converting enzyme inhibition J. Hypertens. Suppl. 10 1 1992 S31 S34
15. B.I. Levy, J.B. Michel, J.L. Salzmann, M. Devissaguet, and M.E. Safar Remodeling of heart and arteries by chronic converting enzyme inhibition in spontaneously hypertensive rats Am. J. Hypertens. 4 3 Pt 2 1991 240S 245S
16. S. Heeneman, J.F. Smits, P.J. Leenders, P.M. Schiffers, and M.J. Daemen Effects of angiotensin II on cardiac function and peripheral vascular structure during compensated heart failure in the rat Arterioscler. Thromb. Vasc. Biol. 17 10 1997 1985 1994
17. V. Robert, C. Heymes, J.S. Silvestre, A. Sabri, B. Swynghedauw, and C. Delcayre Angiotensin AT1 receptor subtype as a cardiac target of aldosterone: role in aldosterone-salt-induced fibrosis Hypertension 33 4 1999 981 986
18. J.S. Silvestre, C. Heymes, A. Oubenaissa, V. Robert, B. Aupetit-Faisant, and A. Carayon Activation of cardiac aldosterone production in rat myocardial infarction: effect of angiotensin II receptor blockade and role in cardiac fibrosis Circulation 99 20 1999 2694 2701
19. C. Delcayre, and B. Swynghedauw Molecular mechanisms of myocardial remodeling. The role of aldosterone J. Mol. Cell. Cardiol. 34 12 2002 1577 1584
20. A. Schafer, D. Fraccarollo, S.K. Hildemann, P. Tas, G. Ertl, and J. Bauersachs Addition of the selective aldosterone receptor antagonist eplerenone to ACE inhibition in heart failure: effect on endothelial dysfunction Cardiovasc. Res. 58 3 2003 655 662
21. R.G. Asmar, B. Pannier, J.P. Santoni, S. Laurent, G.M. London, and B.I. Levy Reversion of cardiac hypertrophy and reduced arterial compliance after converting enzyme inhibition in essential hypertension Circulation 78 4 1988 941 950
22. K.C. Wollert, R. Studer, B. von Bulow, and H. Drexler Survival after myocardial infarction in the rat. Role of tissue angiotensin-converting enzyme inhibition Circulation 90 5 1994 2457 2467
23. M.A. Pfeffer, J.M. Pfeffer, M.C. Fishbein, P.J. Fletcher, J. Spadaro, and R.A. Kloner Myocardial infarct size and ventricular function in rats Circ. Res. 44 4 1979 503 512
24. F. Prunier, R. Gaertner, L. Louedec, J.B. Michel, J.J. Mercadier, and B. Escoubet Doppler echocardiographic estimation of left ventricular end-diastolic pressure after MI in rats Am. J. Physiol. Heart Circ. Physiol. 283 1 2002 H346 H352
25. N.B. Schiller, P.M. Shah, M. Crawford, A. DeMaria, R. Devereux, and H. Feigenbaum Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American society of echocardiography committee on standards, subcommittee on quantitation of two-dimensional echocardiograms J. Am. Soc. Echocardiogr. 2 5 1989 358 367
26. P. Lacolley, P. Challande, S. Boumaza, G. Cohuet, S. Laurent, and P. Boutouyrie Mechanical properties and structure of carotid arteries in mice lacking desmin Cardiovasc. Res. 51 1 2001 178 187
27. G. Cohuet, P. Challande, M. Osborne-Pellegrin, S.M. Arribas, A. Dominiczak, and H. Louis Mechanical strength of the isolated carotid artery in SHR Hypertension 38 5 2001 1167 1171
28. P. Boutouyrie, S. Boumaza, P. Challande, P. Lacolley, and S. Laurent Smooth muscle tone and arterial wall viscosity: an in vivo/in vitro study Hypertension 32 2 1998 360 364
29. P. Boutouyrie, Y. Bezie, P. Lacolley, P. Challande, P. Chamiot-Clerc, and A. Benetos In vivo/in vitro comparison of rat abdominal aorta wall viscosity. Influence of endothelial function Arterioscler. Thromb. Vasc. Biol. 17 7 1997 1346 1355
30. P. Lacolley, E. Glaser, P. Challande, P. Boutouyrie, J.P. Mignot, and M. Duriez Structural changes and in situ aortic pressure-diameter relationship in long-term chemical-sympathectomized rats Am. J. Physiol. 269 2 Pt 2 1995 H407 H416
31. J.K. Bendall, T. Damy, P. Ratajczak, X. Loyer, V. Monceau, and I. Marty Role of myocardial neuronal nitric oxide synthase-derived nitric oxide in beta-adrenergic hyporesponsiveness after myocardial infarction-induced heart failure in rat Circulation 110 16 2004 2368 2375
32. J.B. Michel, A.L. Lattion, J.L. Salzmann, M.L. Cerol, M. Philippe, and J.P. Camilleri Hormonal and cardiac effects of converting enzyme inhibition in rat myocardial infarction Circ. Res. 62 4 1988 641 650
33. Y.M. Pinto, B.G. de Smet, W.H. van Gilst, E. Scholtens, S. Monnink, and P.A. de Graeff Selective and time related activation of the cardiac renin-angiotensin system after experimental heart failure: relation to ventricular function and morphology Cardiovasc. Res. 27 11 1993 1933 1938
34. H. Schunkert, S.S. Tang, S.E. Litwin, D. Diamant, G. Riegger, and V.J. Dzau Regulation of intrarenal and circulating renin-angiotensin systems in severe heart failure in the rat Cardiovasc. Res. 27 5 1993 731 735
35. D.L. Ceiler, H.J. Nelissen-Vrancken, J.G. De Mey, and J.F. Smits Effect of chronic blockade of angiotensin II-receptor subtypes on aortic compliance in rats with myocardial infarction J. Cardiovasc. Pharmacol. 31 4 1998 630 637
36. S. Heeneman, P.J. Leenders, P.J. Aarts, J.F. Smits, J.W. Arends, and M.J. Daemen Peripheral vascular alterations during experimental heart failure in the rat. Do they exist? Arterioscler. Thromb. Vasc. Biol. 15 9 1995 1503 1511
37. P. Lacolley, M.E. Safar, B. Lucet, K. Ledudal, C. Labat, and A. Benetos Prevention of aortic and cardiac fibrosis by spironolactone in old normotensive rats J. Am. Coll. Cardiol. 37 2 2001 662 667
38. P. Lacolley, Y. Bezie, X. Girerd, P. Challande, A. Benetos, and P. Boutouyrie Aortic distensibility and structural changes in sinoaortic-denervated rats Hypertension 26 2 1995 337 340
39. G.L. Baumbach, D.D. Heistad, and J.E. Siems Effect of sympathetic nerves on composition and distensibility of cerebral arterioles in rats J. Physiol. 416 1989 123 140
40. C.A. Tozzi, D.L. Christiansen, G.J. Poiani, and D.J. Riley Excess collagen in hypertensive pulmonary arteries decreases vascular distensibility Am. J. Respir. Crit. Care Med. 149 5 1994 1317 1326
41. A. Benetos, B.I. Levy, P. Lacolley, F. Taillard, M. Duriez, and M.E. Safar Role of angiotensin II and bradykinin on aortic collagen following converting enzyme inhibition in spontaneously hypertensive rats Arterioscler. Thromb. Vasc. Biol. 17 11 1997 3196 3201
42. A. Virdis, M.F. Neves, F. Amiri, E. Viel, R.M. Touyz, and E.L. Schiffrin Spironolactone improves angiotensin-induced vascular changes and oxidative stress Hypertension 40 4 2002 504 510
43. M.H. Al-Shaer, G. Raghuveer, R. Browning, C.A. Sinkey, C. Chenard, and P. Stumbo Effect of hyperhomocysteinemia induced by methionine administration on flow-mediated dilatation of the brachial artery in healthy subjects Am. J. Cardiol. 95 3 2005 428 430
44. G. Arcaro, C. Fava, R. Dagradi, G. Faccini, S. Gaino, and M. Degan Acute hyperhomocysteinemia induces a reduction in arterial distensibility and compliance J. Hypertens. 22 4 2004 775 781
45. J.B. Park, F. Charbonneau, and E.L. Schiffrin Correlation of endothelial function in large and small arteries in human essential hypertension J. Hypertens. 19 3 2001 415 420
46. J.B. Park, and E.L. Schiffrin Small artery remodeling is the most prevalent (earliest?) form of target organ damage in mild essential hypertension J. Hypertens. 19 5 2001 921 930
47. M.K. Nishizaka, M.A. Zaman, S.A. Green, K.Y. Renfroe, and D.A. Calhoun Impaired endothelium-dependent flow-mediated vasodilation in hypertensive subjects with hyperaldosteronism Circulation 109 23 2004 2857 2861
48. R. Rocha, C.T. Stier Jr., I. Kifor, M.R. Ochoa-Maya, H.G. Rennke, and G.H. Williams Aldosterone: a mediator of myocardial necrosis and renal arteriopathy Endocrinology 141 10 2000 3871 3878
49. P. Lacolley, C. Labat, A. Pujol, C. Delcayre, A. Benetos, and M. Safar Increased carotid wall elastic modulus and fibronectin in aldosterone- salt-treated rats: effects of eplerenone Circulation 106 22 2002 2848 2853
50. M. Hayashi, T. Tsutamoto, A. Wada, T. Tsutsui, C. Ishii, and K. Ohno Immediate administration of mineralocorticoid receptor antagonist spironolactone prevents post-infarct left ventricular remodeling associated with suppression of a marker of myocardial collagen synthesis in patients with first anterior acute myocardial infarction Circulation 107 20 2003 2559 2565
51. D.A. Duprez, M.L. De Buyzere, E.R. Rietzschel, Y. Taes, D.L. Clement, and D. Morgan Inverse relationship between aldosterone and large artery compliance in chronically treated heart failure patients Eur. Heart J. 19 9 1998 1371 1376
52. J. Blacher, G. Amah, X. Girerd, A. Kheder, H. Ben Mais, and G.M. London Association between increased plasma levels of aldosterone and decreased systemic arterial compliance in subjects with essential hypertension Am. J. Hypertens. 10 12 Pt 1 1997 1326 1334
53. B.I. Levy, J.L. Salzmann, M. Devissaguet, M.E. Safar, and J.B. Michel Angiotensin converting enzyme (ACE) inhibitors in experimental hypertension: influence on heart and arteries Basic Res. Cardiol. 86 Suppl 1 1991 43 53
54. B. Pitt, G. Williams, W. Remme, F. Martinez, J. Lopez-Sendon, and F. Zannad The EPHESUS trial: eplerenone in patients with heart failure due to systolic dysfunction complicating acute myocardial infarction. Eplerenone Post-AMI Heart Failure Efficacy and Survival Study Cardiovasc. Drugs Ther. 15 1 2001 79 87
55. S. Laurent, P. Boutouyrie, R. Asmar, I. Gautier, B. Laloux, and L. Guize Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients Hypertension 37 5 2001 1236 1241
56. D.M. Herrington, K. Kesler, J.C. Reiber, W. Davis, W.V. Brown, and R. Helms Arterial compliance adds to conventional risk factors for prediction of angiographic coronary artery disease Am. Heart J. 146 4 2003 662 667
57. G.J. Langewouters, K.H. Wesseling, and W.J. Goedhard The static elastic properties of 45 human thoracic and 20 abdominal aortas in vitro and the parameters of a new model J. Biomech. 17 6 1984 425 435